NPF News

NPF Announces an Exciting New Venture

Categories: News, NPF News, Other
The National Pancreas Foundation to Develop the First National Patient Registry The registry will bring together data from patients and cutting-edge researchers, all working to improve care and develop new and better therapies for individuals suffering from pancreatic disease. BETHESDA, MD – July 10, 2014 – The National Pancreas Foundation (NPF), a nonprofit organization that …

Read More

2014 Courage for a Cure Gala

Categories: News, NPF News, Other

The National Pancreas Foundation’s “Courage for A Cure” Gala Hits A Home Run! July 1, 2014 – PNC Park, home of the Pittsburgh Pirates, was the perfect setting for the annual Courage for a Cure Gala hosted by the Western Pennsylvania Chapter of the National Pancreas Foundation (NPF). Held on Friday, June 20th, the event …

Read More

Long-term use of aspirin may reduce risk for pancreatic cancer

Categories: News, NPF News, Other

Continual use of low-dose or regular-dose aspirin may cut a person’s risk of developing pancreatic cancer in half, a Yale School of Public Health and Yale Cancer Center study has found. Further, the degree of protection may grow the longer one takes the aspirin. The study appears in the journal Cancer Epidemiology, Biomarkers & Prevention. …

Read More

ChiRhoClin announces the availability of ChiRhoStim

Categories: News, NPF News, Other

ChiRhoClin, Inc. announces the availability of ChiRhoStim® (Human Secretin for injection) to the medical community. (Burtonsville, Maryland) ChiRhoStim® (Human Secretin for injection) is now commercially available to the medical community.  ChiRhoStim® batch #0636149 was manufactured in June 2013 in a new manufacturing facility and has met all product release and sterility tests. This new facility …

Read More

Easing the Pain of Chronic Pancreatitis

Categories: NPF News, Other, Uncategorized
Patients with chronic pancreatitis often face severe, unrelenting pain with little or no relief. There is no cure for this progressive disease but a new surgical treatment offered at Dartmouth-Hitchcock offers hope to patients like Jennifer Bowen, who once thought a normal life would never be possible.  To view Jennifer’s story, please visit here.   …

Read More